Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04574895 · ClinicalTrials.gov registry record · NA
Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events
A NA study of Pulmonary Embolism and Venous Thromboembolism, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 17,427
- Enrollment target
- 1
- Study location
NCT04574895: Completed NA study of Pulmonary Embolism and Venous Thromboembolism, sponsored by Vanderbilt University Medical Center.
NCT04574895 is a NA study of Pulmonary Embolism and Venous Thromboembolism that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 17,427 participants, above the 2,695-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (547% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04574895, a NA study of Pulmonary Embolism and Venous Thromboembolism, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17,427 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will evaluate the effectiveness of a novel, real-time risk prediction model for identifying pediatric patients at risk for developing in-hospital blood clots (or venous thromboembolism \[VTE\]) based on data easily extracted from the electronic medical record. The study will assess whether using the risk percentages for developing VTE derived from the model increases the number of high-risk patients screened by the pediatric hematology team, which may may lead to an overall reduction in the number of pediatric VTEs seen at Monroe Carell Jr. Children's Hospital at Vanderbilt.
Primary Outcome
Number of VTE events per hospital admission encounter, per study arm. A VTE event will be defined as an acute venous thromboembolic event (e.g. deep vein thrombosis, pulmonary embolism, etc).
Conditions Studied
Interventions
- OTHER Hematology Review
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,427 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2023-12-01 |
| Phase | NA |
What the finished NCT04574895 record still lists
NCT04574895 is an interventional study that assigns participants to a tested intervention. Its 17,427 participants enrollment target places it among the larger protocols in the corpus, above the 2,695-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (547% higher).
The record links to 4 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 1 intervention - of which Hematology Review is the first listed.
NCT04574895 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT04574895 about?
NCT04574895 is a clinical study titled "Using a Real-Time Risk Prediction Model to Predict Pediatric Venous Thromboembolism (VTE) Events". The study will evaluate the effectiveness of a novel, real-time risk prediction model for identifying pediatric patients at risk for developing in-hospital blood clots (or venous thromboembolism \[VTE\]) based on data easily extracted from the electronic medical record. The study will assess whether...
What is the current status of trial NCT04574895?
This trial is currently completed. It is a NA study. The enrollment target is 17,427 participants. The study started on 2020-11-02. Estimated completion is 2023-12-01.
What conditions does trial NCT04574895 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Venous Thromboembolism, Deep Vein Thrombosis, Pediatrics.
What interventions are being tested in trial NCT04574895?
The interventions under investigation include: Hematology Review (OTHER).
Who is sponsoring clinical trial NCT04574895?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04574895 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04574895's enrollment target sits among peer trials
17,427 2nd of 48 the highest of 48 other Pulmonary Embolism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Embolism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
The PEERLESS II Study
RECRUITING · NA
-
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06272110 · 17,500 participants
Promoting Equitable Access to Language Services in Health and Human Services
- NCT07290361 · 17,587 participants · NA
Stratified Targeted Engagement From Primary Care to Physical Therapy (STEPPT)
- NCT06245187 · 17,198 participants
Get With the Guidelines Atrial Fibrillation Registry
- NCT07108660 · 17,800 participants · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI